Welcome to our dedicated page for Inflection Point Acquisition IV SEC filings (Ticker: BACQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Inflection Point Acquisition Corp. IV (BACQ) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as a Nasdaq-listed blank check company. Inflection Point Acquisition Corp. IV, a Cayman Islands exempted company and emerging growth company, files current and periodic reports with the U.S. Securities and Exchange Commission that describe its capital structure, governance and proposed business combination activities.
Among the key documents available are multiple Forms 8-K detailing material events. A filing dated September 23, 2025 describes the Business Combination Agreement between Bleichroeder Acquisition Corp. I (which will be renamed Inflection Point Acquisition Corp. IV), a merger subsidiary and Merlin Labs, Inc., a developer of assured, autonomous flight technology for defense customers. This 8-K also discusses a strategic partnership between Merlin Labs and GE Aerospace and notes that Inflection Point Acquisition Corp. IV and Merlin Labs are contemplating additional private placement financing in connection with the business combination.
An 8-K dated October 21, 2025 reports shareholder approval of changing the company’s name to Inflection Point Acquisition Corp. IV and amending its articles to modify redemption timing for public shares. Another 8-K dated November 17, 2025 outlines amendments to a Securities Purchase Agreement and additional securities purchase agreements that increase PIPE commitments for preferred stock and warrants to be issued by New Merlin Labs in connection with the transaction.
Through this filings page, users can review these 8-Ks, the definitive proxy statement on Schedule 14A regarding the name change and article amendments, and future registration statements on Form S-4 related to the proposed business combination. Stock Titan enhances this access with AI-powered summaries that highlight the main terms of the business combination, changes to shareholder rights, and details of PIPE and pre-funded note financings, helping readers interpret BACQ’s SPAC-related disclosures more efficiently.
Merlin, Inc. disclosed that its CFO and Treasurer, Ryan Michael Carrithers, filed an initial statement of beneficial ownership on Form 3. The filing lists him as an officer but does not report any specific stock transactions or derivative holdings at this time.
Merlin, Inc. filed an initial insider ownership report for George Matthew Spencer, who serves as both Chief Executive Officer and director. This Form 3 does not list any stock or option transactions and shows no reported holdings or derivative positions for him at this time.
Merlin, Inc. director Michael Montelongo filed an initial Form 3 reporting his beneficial ownership position in the company’s securities. This filing establishes his status as an insider for disclosure purposes. The data excerpt shows no buy, sell, or other reportable transactions at this time.
Merlin, Inc. filed an initial insider ownership report (Form 3) for Leslie Renee Ravestein, who serves as CLO and Secretary. The data provided shows no reported transactions, exercises, gifts, or holdings in this filing, indicating a baseline disclosure of insider status rather than trading activity.
Merlin, Inc. director Smith Robert Hanson filed an initial Form 3 insider ownership report. The filing does not list any buy or sell transactions and serves to register his status as a reporting insider for future ownership and trading disclosures.
Merlin, Inc. director Carolyn Trabuco filed an initial Form 3, which is a required statement of beneficial ownership for new insiders. The data provided shows no reported purchases, sales, exercises, gifts, or other transactions, indicating this is a baseline disclosure of insider status rather than a trading event.
Merlin, Inc. reported that Bleichroeder Sponsor 1 LLC, the SPAC sponsor, converted its derivatives into common equity in connection with the closing of the business combination with Merlin Labs, Inc. Each Class B ordinary share converted into one Class A ordinary share and then into one share of common stock.
The sponsor converted 8,333,333 Class B ordinary shares into 8,333,333 Class A ordinary shares and then common stock, and 425,000 rights into 42,500 shares of common stock, all at an exercise price of $0. Following these transactions, the sponsor holds 8,800,833 shares of common stock directly.
MC Advisory L.L.C-FZ, managed by co-founder Michel Combes, and former executive chairman Andrew Gundlach are managing members of the sponsor and have voting and investment discretion over these shares, while each disclaims beneficial ownership beyond any pecuniary interest.
Inflection Point Acquisition Corp. notified the removal of its Rights, Units from listing and registration on the Nasdaq Stock Market LLC. The Form 25 cites Nasdaq compliance with 17 CFR 240.12d2-2 and the issuer's compliance with the Exchange's rules for voluntary withdrawal; an expiry date appears as March 31, 2018.
Inflection Point Acquisition Corp. IV is a Cayman Islands SPAC that raised $250,000,000 in its IPO by selling 25,000,000 units at $10.00 each, with proceeds held in a U.S. trust account for an eventual business combination.
The company has agreed to a proposed business combination with Merlin Labs, Inc., valuing Merlin at a $800,000,000 purchase price, with consideration in New Merlin Common Stock determined by the per-share redemption price. The structure includes domestication to Delaware, a merger via a wholly owned merger sub, and a post-closing name change to Merlin, Inc.
Supportive financing includes approximately $78 million plus $9.3 million of Merlin pre-funded convertible notes and warrants, and a Series A preferred PIPE totaling $100 million from a lead investor and $20 million from additional investors. Shareholders and Merlin stockholders approved the transaction, and Inflection Point expects to close the business combination on March 16, 2026, after offering public shareholders redemption rights and satisfying regulatory and listing conditions.